ENTITY

Context Therapeutics (CNTX US)

Analysis

Health Care • United States

Context Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on development of medicines and novel therapies for the treatment of female cancer patients. Context Therapeutics serves customers in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00